Article
Session 3: Discussant
Author(s):
Jan Berger, MD, MJ, The American Journal of Pharmacy Benefits editor-in-chief, follows Rebecca Killon's remarks with her own insight on the importance of diabetes medication adherence.
Jan Berger, MD, MJ, The American Journal of Pharmacy Benefits editor-in-chief, follows Rebecca Killon’s remarks with her own insight on the importance of diabetes medication adherence.
“I've waited 13 years for adherence to be an important issue. In 2003, when I first got somebody's attention, they looked at me like I was crazy,” said Dr Berger. “It was just a matter of [what] doctors would say to us when we would share with them that their patient was nonadherent. ‘It's not my problem,’ ‘ It's not my fault,’ ‘ It's the patient, we told them what to do.‘“
Dr Berger argues that the only way to truly have a breakthrough, is in the power of physician-patient relationships and alignment. Through better communication, continual learning, and realistic expectations, we can improve adherence rates.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
